Why Do We Have So Much Red Tape In Pharma Industry

Solutions OP Clinical Trials UK
18/02/2025 12 min Episodio 24
Why Do We Have So Much Red Tape In Pharma Industry

Listen "Why Do We Have So Much Red Tape In Pharma Industry"

Descargar episodio Ver en sitio original

Episode Synopsis

This episode covers the reasons for red tape in the pharma industry and how to improve the interactions between the pharma industry and the regulators. The answer to the question who is responsible for the increasing red tape in the drug development is not simple but both the regulators and the pharma industry have to admit their contribution.

More episodes of the podcast Solutions OP Clinical Trials UK

Key Messages from Regulatory Intelligence Conference and How They Affect Startups 28/11/2025
How to engage more patients in clinical trials: Interview With Keith Berelowitz 14/11/2025
The Role Of Nurse Practitioners In Clinical Research: Interview With Steven Edmunds 31/10/2025
Why Is The UK Losing The Big Pharma Investment 17/10/2025
Is The FDA Chemistry Manufacturing Controls Pilot Program Helpful For Pharma Startups? 03/10/2025
Finding Your First Job In Clinical Research: Discussion with Harry Henson 19/09/2025
Enhancing Medical Devices Informed Consent Forms: Discussion With Lydia Ainsworth 05/09/2025
AI and The Future of Medical Diagnostics: Conversation with Georgi Kadrev 22/08/2025
What Has Changed In The New GCP 2025 08/08/2025
Latest Trends and The Future of Cancer Research: Conversation with Charles Theuer 25/07/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA